Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LIFECORE BIOMEDICAL, INC. \DE\
Report date January 16, 2020 · Filed January 17, 2020
Section 16 reporting ended · disclosed 2020-01-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 301,219 |
Ending reported balance
After 2020-01-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-01-16 · Grant · Acquired 7,000 · Balance 295,036 Row 2 · 2020-01-16 · Grant · Acquired 6,183 · Balance 301,219 |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-01-16 | Direct | 0 |
Reported balance
After 2020-01-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-01-16 · Exercise / conversion · Disposed 7,000 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on October 19, 2017. F3: Vesting of restricted stock units was accelerated on January 16, 2020 by reason of Separation Agreement. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Expires 2020-01-16 | Direct | 0 |
Reported balance
After 2020-01-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-01-16 · Exercise / conversion · Disposed 6,183 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4: The restricted stock units were granted on July 25, 2018. F3: Vesting of restricted stock units was accelerated on January 16, 2020 by reason of Separation Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on October 19, 2017.
F3: Vesting of restricted stock units was accelerated on January 16, 2020 by reason of Separation Agreement.
F4: The restricted stock units were granted on July 25, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2020 Filed Jan 17, 2020 18:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 6,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-000385 · wf-form4_157928639631567.xml · derivative · entry 4 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,183 shares Expires 2020-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F4 · shares: The restricted stock units were granted on July 25, 2018. F3 · derivative.exercise_date: Vesting of restricted stock units was accelerated on January 16, 2020 by reason of Separation Agreement. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 18:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-000385 · wf-form4_157928639631567.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2020-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 19, 2017. F3 · derivative.exercise_date: Vesting of restricted stock units was accelerated on January 16, 2020 by reason of Separation Agreement. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 18:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 6,183 | $11.12 | $68,754.96 |
DisclosureSEC source: 0001628280-20-000385 · wf-form4_157928639631567.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,219 Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 18:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 7,000 | $11.12 | $77,840.00 |
DisclosureSEC source: 0001628280-20-000385 · wf-form4_157928639631567.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,036 Read SEC document |
| January 08, 2019 Filed Jan 9, 2019 19:40 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | PurchaseCommon Stock | 25,000 | $11.25 | $281,250.00 |
DisclosureSEC source: 0001437749-19-000594 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,036 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.80 to $11.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 22:32 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 8,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-018629 · rdgdoc.xml · derivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,913 shares Expires 2018-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 20, 2016. F3 · derivative.exercise_date: The restricted stock units vested on October 20, 2018. Read SEC document |
| October 20, 2018 Filed Oct 23, 2018 22:32 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 8,913 | $14.11 | $125,762.43 |
DisclosureSEC source: 0001437749-18-018629 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 6,229 | $14.35 Strike: $14.35 | $89,386.15 |
DisclosureSEC source: 0001437749-18-013907 · rdgdoc.xml · derivative · entry 4 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,550 Underlying: Common Stock · 6,229 shares Expires 2025-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionNonqualified Stock Option (Right to Buy) · Derivative | 12,321 | $14.35 Strike: $14.35 | $176,806.35 |
DisclosureSEC source: 0001437749-18-013907 · rdgdoc.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,321 Underlying: Common Stock · 12,321 shares Expires 2025-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 9,930 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-013907 · rdgdoc.xml · derivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,930 Underlying: Common Stock · 9,930 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.exercise_date: Restricted Stock Units will be automatically settled in shares of common stock subject to achievement of the performance goals set forth in the Company's LTIP for 2021. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 20:23 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 6,183 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-18-013907 · rdgdoc.xml · derivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,183 Underlying: Common Stock · 6,183 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into Common Stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-010767 · rdgdoc.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2018-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 28, 2015. F3 · derivative.exercise_date: The restricted stock units vested on May 23, 2018. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 5,151 | $13.65 | $70,311.15 |
DisclosureSEC source: 0001437749-18-010767 · rdgdoc.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,123 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 15,000 | $13.65 | $204,750.00 |
DisclosureSEC source: 0001437749-18-010767 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 20:25 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,913 | $13.00 Strike: $13.00 | $115,869.00 |
DisclosureSEC source: 0001437749-17-017449 · rdgdoc.xml · derivative · entry 5 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,913 Underlying: Common Stock · 8,913 shares Expires 2017-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 20:25 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 3,349 | $13.00 | $43,537.00 |
DisclosureSEC source: 0001437749-17-017449 · rdgdoc.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,274 Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 20:25 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 8,913 | $13.00 | $115,869.00 |
DisclosureSEC source: 0001437749-17-017449 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,913 | $13.00 Strike: $13.00 | $115,869.00 |
DisclosureSEC source: 0001437749-17-017441 · rdgdoc.xml · derivative · entry 5 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,913 Underlying: Common Stock · 8,913 shares Expires 2017-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 3,349 | $13.00 | $43,537.00 |
DisclosureSEC source: 0001437749-17-017441 · rdgdoc.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,274 Read SEC document |
| October 20, 2017 Filed Oct 23, 2017 19:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 8,913 | $13.00 | $115,869.00 |
DisclosureSEC source: 0001437749-17-017441 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:25 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 7,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-017449 · rdgdoc.xml · derivative · entry 4 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2020-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 20:25 UTC Amendment | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 21,000 | $12.65 Strike: $12.65 | $265,650.00 |
DisclosureSEC source: 0001437749-17-017449 · rdgdoc.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Stock · 21,000 shares Expires 2024-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 7,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-017441 · rdgdoc.xml · derivative · entry 4 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 7,000 shares Expires 2020-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · derivative.exercise_date: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit. Read SEC document |
| October 19, 2017 Filed Oct 23, 2017 19:04 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 21,000 | $12.65 Strike: $12.65 | $265,650.00 |
DisclosureSEC source: 0001437749-17-017441 · rdgdoc.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Stock · 96,000 shares Expires 2024-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:41 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 43,678 | $0.00 Strike: $5.63 | $0.00 |
DisclosureSEC source: 0001437749-17-000330 · rdgdoc.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 43,678 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:41 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 17,196 | $14.30 | $245,902.80 |
DisclosureSEC source: 0001437749-17-000330 · rdgdoc.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,710 Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 21:41 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 43,678 | $5.63 | $245,907.14 |
DisclosureSEC source: 0001437749-17-000330 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 08, 2016 Filed Dec 13, 2016 00:03 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | OtherNon-Qualified Stock Option (Right to Buy) · Derivative | 31,322 | $5.63 Strike: $15.30 | $176,342.86 |
DisclosureSEC source: 0001437749-16-043238 · rdgdoc.xml · derivative · entry 3 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,322 shares Expires 2017-05-26 Read SEC document |
| December 08, 2016 Filed Dec 13, 2016 00:03 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Tax withholdingCommon Stock | 18,964 | $15.30 | $290,149.20 |
DisclosureSEC source: 0001437749-16-043238 · rdgdoc.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,228 F1 · shares: Mr Skinner surrendered to the Issuer the right to receive an aggregate of 18,964 shares of Common Stock. Mr. Skinner did not sell any shares of Common Stock in connection with the foregoing exercise. Read SEC document |
| December 08, 2016 Filed Dec 13, 2016 00:03 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 31,322 | $15.30 | $479,226.60 |
DisclosureSEC source: 0001437749-16-043238 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 16:13 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 39,214 | $14.00 | $548,894.04 |
DisclosureSEC source: 0001437749-16-041938 · rdgdoc.xml · nonDerivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,870 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.85 to $14.6750, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 16:13 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | SaleCommon Stock | 10,786 | $13.96 | $150,601.68 |
DisclosureSEC source: 0001437749-16-041938 · rdgdoc.xml · nonDerivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,084 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.90 to $14.0505, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 23:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-16-040135 · rdgdoc.xml · derivative · entry 2 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,913 Underlying: Common Stock · 8,913 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| October 20, 2016 Filed Oct 24, 2016 23:46 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,913 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-16-040135 · rdgdoc.xml · derivative · entry 1 SKINNER GREGORY S · CIK 0001192864 · VP Finance and Admin & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,913 Underlying: Common Stock · 8,913 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F3 · derivative.expiration_date: Restricted Stock Units will vest on the 2nd anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.